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TOLL-LIKE RECEPTOR 2 (TLR2) REGULATES NEUTROPHIL 
PRODUCTION IN DIET-INDUCED OBESITY 
 
BRYAN HUANG 
ABSTRACT 
 
Background: Obesity has become increasingly prevalent due to over-nutrition and 
sedentary lifestyle. While many past studies have identified a link between metabolic 
dysfunction and tissue inflammation, molecular mechanisms that initiate and propagate 
inflammation remain unclear. In this study, we investigated the role of Toll-like receptor-
2 (TLR2) in modulating inflammatory response in mice and examined the effect of high-
fat diet (HFD)-induced myelopoiesis and systemic inflammation. 
Objective: To investigate the role of TLR2 in regulating the HFD-induced myelopoiesis 
and systemic inflammation.  
Methods: After HFD-feeding for 12 weeks, mouse bone marrow (BM) cells and 
peripheral blood leukocytes were isolated. Mouse BM hematopoietic progenitor cells 
(HSPCs) were enriched using a HSPC enrichment kit. Isolated HSPCs were used for 
RNA purification, FACS analysis, and RT-qPCR. Statistical analysis was performed on 
FACS and RT-qPCR data. 
Results: Compared to WT mice, TLR2 KO mice demonstrated significant reduction in 
the mRNA expression in HSPCs of C/EBPα, C/EBPε, GFI-1, PU.1, and Runx1, which 
are all transcription factors involved in myeloid cell differentiation. FACS analysis 
 vi	
showed a substantial percentage reduction in BM neutrophils and increase in BM 
lymphocytes in TLR2 KO mice in comparison to WT mice. Interestingly, the percentage 
of blood B-lymphocyte of TLR2 KO mice was also markedly decreased. 
Conclusions: HFD feeding activates TLR-dependent C/EBPα-GFI-1 pathway required 
for myelopoiesis and systemic inflammation. Given that the deletion of TLR2 is 
sufficient to reverse the long-term HFD-induced molecular changes and neutrophil 
production, TLR2 may be involved in obesity-related systemic tissue inflammation.  
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INTRODUCTION 
 
The Emergence of Obesity As a Nationwide Epidemic  
The obesity epidemic has long been a top-priority concern that the U.S. healthcare 
industry and medical sector are working to address. According to a nutrition examination 
survey done by NIH in 2010, more than two-thirds of adults and one-third of children and 
adolescents are considered to be overweight or obese. Nearly 74 percent of men fall into 
this category. Due to the sedentary lifestyle that many people are disposed to in the 
modern day environment, they become at higher risk of gaining excessive weight and 
developing health problems later on in life. Obesity is of particular concern in the 
younger population because obesity induces a tonic low-grade activation of the innate 
immune system that alters steady-state measures of metabolic homeostasis over time.  
 
Since inflammatory markers are elevated in obese children as young as 3 years 
old, childhood obesity can potentially develop into a lifelong metainflammation (Skinner, 
2010).  A wide range of diseases, including diabetes, cardiovascular diseases, fatty liver 
disease, sleep apnea, arthritis, and various cancers, are associated with obesity. Since 
excessive body fat triggers changes to the body’s metabolism, it can lead to an 
uncontrolled release of fat molecules by adipose tissues into the blood. In addition to 
nonalcoholic fatty liver and cardiovascular diseases, one of the major outcomes is Type 2 
Diabetes Mellitus (T2DM) that is characterized by glucose intolerance and insulin 
insensitivity. Suffering from insulin resistance, patients with T2DM struggle to maintain 
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appropriate blood sugar levels with hyperglycemia especially after meals. Nonetheless, 
while meaningful findings have been discovered in the field, the precise molecular 
mechanisms involved in the development of obesity and related complications remain 
unclear and require further investigation.  
 
Diet-induced Obesity is Closely Associated with Fat Tissue Inflammation 
Several recent studies have identified the link between obesity and chronic 
adipose tissue inflammation. Inflammation, typically emerges as a coordinated response 
to harmful stimuli, is characterized by a systemic increase in circulating inflammatory 
cytokines and acute phase proteins (e.g., C-reactive protein), leukocyte recruitment to the 
inflamed tissues, and the generation of reparative tissue responses (e.g., fibrosis) 
(Spencer, 2010). The massive recruitment of immune cells to adipose tissue marks a 
ubiquitous finding in subjects with obesity and T2DM. Proinflammatory cytokines such 
as IL-1 and TNFα, which are crucial in cell signaling to promote systemic inflammation 
in response to the exposure to foreign antigens are greatly expressed in this condition, 
whereas anti-inflammatory adipokines with protective features such as adiponectin have 
reduced production (Hotamisligil, 2006; Kamei, 2006; Lumeng and Saltiel, 2011; Ouchi, 
2011; Shoelson, 2006). Subsequently, in response to the proinflammatory cytokine 
signals, proinflammatory cells including mast cells, lymphocytes, NK cells, and 
neutrophils infiltrate adipose tissue in the early stages of obesity, and macrophage 
recruitment occurs at later times (Elgazar-Carmon, 2008; Feuerer, 2009; Liu, 2009; 
Nishimura, 2009; Weisberg, 2003; Winer, 2011; Xu, 2003).  
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Once neutrophils and macrophages arrive in adipose tissue, they begin secreting 
neutrophil elastase (NE), a serine proteinase in the same family as chymotrypsin with 
broad substrate specificity, to digest foreign bodies and host tissues through protein 
hydrolyzation (Dale, 2001). A previous study performed by our lab demonstrated that NE 
plays a role in regulating de novo synthesis of neutrophil by changing the expression of 
key transcription factors. Given that NE possesses destructive characteristics when 
activated, mice depleted of NE were found to have reduced leukocyte leakage, vascular 
damage, and systemic inflammation (Huang, 2017).  
 
While it is necessary to have a robust endogenous defense mechanism against 
pathogens, the unwanted damage can be significant if the secretion of this digestive 
enzyme is left unregulated. To confirm the theory, a study demonstrated that obese mice 
and humans have increased activity of NE and decreased serum levels of the NE inhibitor 
α1-antitrypsin such as A1AT (Mansuy-Aubert, 2013). NE-knockout mice and A1AT 
transgenic mice were resistant to HFD-induced body weight gain, insulin resistance, fatty 
liver, and adipose tissue inflammation. These mice also showed elevated levels of 
circulating high molecular weight adiponectin. Increases in circulating cytokines, 
decreases in protective factors (e.g., adiponectin), and communication between 
inflammatory and metabolic cells all serve as possible inflammatory inputs that lead to 
metabolic dysfunction (Lumeng & Saltiel, 2011; Hotta, 2000; Hotamisligil, 1995). 
Additionally, signals from activated conventional T cells such as IFNγ were capable of 
disrupting glucose transport and inducing adipocyte inflammation (Feuerer, 2009). 
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Accumulation of Immune Cells in Inflamed Adipose Tissue May Explain the 
Metabolic Dysfunction  
Relevant studies revealed that proinflammatory changes with obesity are tissue-
specific. In pancreatic islets, an inflamed tissue can reduce insulin secretion and trigger β 
cell apoptosis. The outcome is a reduction of islet mass, a common occurrence in the 
progression of diabetes (Ehses, 2008; Donath, 2010). Although many factors contribute 
to the pancreatic islet destruction, macrophages that are accumulated in islets with HFD 
are hypothesized to be an important source of proinflammatory cytokines that cripples β 
cell function (Ehses, 2007). In adipose tissue, inflammation can lead to insulin resistance 
and dysfunctional lipid storage. Previous findings have linked impaired lipogenic 
capacity with the increases of visceral fat in obese adolescents. It is believed that the 
storage capacity of adipose tissues may be saturated by unoxidized long-chain fatty acids, 
leading to lipid deposition in non-adipose tissues (e.g., heart and liver) and the promotion 
of metabolic diseases (Kursawe, 2010). Similar to the effects of obesity on adipose tissue, 
nonalcoholic fatty liver disease is associated with increased proinflammatory cytokines 
(Li, 2005). 
 
It was found that the expression of many signaling and metabolic pathways 
involving TLR4 was elevated in steatotic liver, increasing the risk of developing insulin 
resistance in hepatocytes (Fabbrini, 2009). Additionally, given that myocytes are capable 
of responding to inflammatory signals via pattern recognition receptors such as TLRs 
with direct metabolic effects, there is evidence of elevated inflammatory cytokine 
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production and inflammation in obese skeletal muscle (Saghizadeh, 1996; Frisard, 2010). 
This muscle inflammation is speculated to be associated with M1-activated macrophage 
infiltration originally set off by HFD feeding (Hong, 2009). With the estimate of an 
additional 20-30 million macrophages with each kilogram of excess fat in humans, it is 
implied that increased adipose tissue mass and increased inflammatory mass are not 
mutually exclusive (O’Rourke, 2009).  
 
Toll-like Receptors (TLRs) Contribute to HFD-induced Inflammation via LPS-induced 
Signaling Pathway 
It has been established that key proinflammatory cytokines and nuclear factors 
mediate the inflammatory pathways through various molecular mechanisms. For one, 
pattern recognition receptors (PRRs) of the innate immune system are capable of 
detecting foreign molecules and initiating an appropriate defense response. However, it 
was discovered that PRRs can mistaken endogenous ligands induced in obesity as foreign 
antigens and elicit an inflammatory response. Among these PRRs, Toll-like Receptor 2 
(TLR2), which can be activated by free fatty acids to generate proinflammatory signals, 
plays a key role in mediating obesity-induced inflammation and insulin resistance that are 
caused by lipid infusion (Shi, 2006; Fessler, 2009).  
 
While it has been known that TLR2 receptors are widely found on the surface of 
fat tissue, HSPCs, and GI system (Yanez, 2013; Boulard, 2010; Davis, 2011), the 
mechanisms through which tissue-specific TLR2 receptors regulate inflammatory 
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pathways remain poorly understood. In past studies, TLR2 knock-out mice were shown 
to be protected from HFD-induced obesity and insulin resistance (Himes, 2010). 
Additionally, TLR family of PRRs demonstrates keen sensitivity to obesity-induced 
signals. These receptors are activated by signals from stressed or dying cells to mobilize 
leukocytes to affected areas (Chen, 2009). TLR activation stimulates production of IL-1β 
and IL-18 via Caspase-1 in macrophages (Sahoo, 2011). This particular mechanism 
contributes to pancreatic β cell death with chronic hyperglycemia and exacerbates 
diabetic pathology (Zhou, 2010). Moreover, Caspase-1 and IL-1β expression is also 
intensified in adipose tissue with diet-induced obesity, leading to a large abundance of 
proinflammatory signals in the circulation (Vandanmagsar, 2011).  
 
With the intracellular activation of IκB Kinase-β (IKKβ) that occurs downstream 
of TLR activation, NF-κB-dependent activation of inflammatory gene transcription is 
switched on (Baker, 2011). However, NF-κB may also play an anti-inflammatory role in 
certain context. In order to prevent prolonged and uncontrolled inflammation, a former 
study demonstrated that NF-κB might play a role in regulating the expression of anti-
inflammatory genes and the induction of leukocyte apoptosis during later stages of 
inflammation (Lawrence, 2001). The clearance of inflammatory cells signifies the 
termination of immune responses. It turns out that NF-κB possesses both pro- and anti-
inflammatory characteristics in this signaling pathway, adding another layer of 
complexity to the understanding of signal transduction mechanism in inflammation. 
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Contrary to former belief, pathways that involve this particular nuclear factor may turn 
out to be difficult targets for chronic disease treatment.  
 
The introduction of HFD induces leukocyte infiltration and inflammation in 
adipose tissue as well as increased circulating proinflammatory cytokines. The abundant 
fat and energy intake associated with HFD elevate plasma and fecal lipopolysaccharide 
(LPS) levels that lead to dysregulation of the gut microbiota, a collection of symbiotic 
microorganisms that harbors in animal digestive tracts (Yang, 1998; Kim, 2012; 
Pendyala, 2012). The outcomes usually include increases in cytokines and inflammatory 
mediators, reactive oxygen species, and ultimately the acceleration of metabolic 
syndrome (Chakraborty, 2010). Serving as a major component that maintains the 
structural integrity of gram-negative bacteria, LPS typically induces a strong immune 
response by being identified as an invading pathogen (Alexander, 2001). Upon binding 
with LPS, TLRs interact with multiple regulatory factors that enhance the expression of 
many proinflammatory cytokines, including TNFα and NF-κB (Andreakos, 2004). LPS-
induced cellular signaling in myeloid cells is highly depended on LPS-binding protein 
and CD14, both acting as important mediators to the signaling pathway (Zanoni, 2011).  
 
TLR2 Activation Can Trigger Emergency Myelopoiesis During Uncontrolled Infection 
LPS invasion can have a tremendous impact on the innate immune system. In the 
case where microbial infection cannot be contained locally, neutrophils are used up in 
enormous quantities and the hematopoietic system (i.e., the bone marrow) is required to 
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rapidly adapt to the increased demand by switching from steady-state to emergency 
myelopoiesis. Starting with enhanced myeloid precursor cell proliferation, neutrophil 
count is markedly increased via de novo production in the bone marrow (BM). While the 
transcription factors that favor myelopoiesis are upregulated, those that are involved in 
lymphopoiesis are downregulated. A recent study done in our lab confirmed this finding 
with the conclusion that HFD feeding selectively activates transcription factors that favor 
myelopoiesis at the expense of lymphopoiesis in BM (Huang, 2017).  
 
Studies also demonstrated that TLR agonists drive HSPCs to proliferate and 
differentiate along the myeloid lineage in vitro (Yanez, 2013). HFD-induced neutrophil 
homeostasis is achieved through regulating multiple transcription factors that are 
involved in BM myelopoiesis and neutrophil production. Myelopoiesis can be enhanced 
through not only cytokines and growth factors exclusively, but also direct interaction of 
HSPCs with microbes and microbial components. Multiple studies have shown that 
leukocyte response can be programmed by TLR signaling in HSPCs prior to and/or 
during differentiation, as the body needs to react promptly to the exposure of invading 
species. Essentially, TLR activation of HSPCs behaves as a compensatory mechanism to 
generate more phagocytes to aid in immune defense.  
 
Obesity-induced Adipose Tissue Fibrosis Can Accelerate Metabolic Dysfunction 
Normally, wounds are healed and repaired to restore the original tissue structure 
and functional integrity. However, prolonged chronic inflammatory stimuli may cause 
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deregulation of normal processes that lead to extracellular matrix (ECM) build-up and 
fibrosis (Lee, 2010). Recent studies have shown that excess levels of ECM and fibrosis 
occur in WAT depots of obese individuals (Henegar, 2008).  Tissues of fibrotic organs 
are replaced by the deposition of collagen-rich ECM, potentially leading to organ failure. 
There has been evidence that obese mice showed improvement in glucose tolerance and 
insulin sensitivity after being targeted for ECM remodeling (Khan, 2009). It is likely that 
WAT fibrosis represents a maladaptive mechanism that gives rise to comorbid obesity-
related metabolic complications (Marcelin, 2017).  
 
It is generally believed that fibrosis is mediated by circulating fibrocytes, which 
are BM-derived mesenchymal progenitor cells that express a variety of cell-surface 
markers related to leukocytes, HSPCs, and fibroblasts (Strieter, 2009). These cells, when 
activated, will locally transform into myofibroblasts (Wynn, 2008). Studies have 
suggested that these cells serve an important role in the pathogenesis of tissue fibrosis 
(Phillips, 2004). While we have compelling evidence that WAT fibrosis contributes to the 
exacerbation of metabolic dysfunction, the cellular origin of profibrotic molecules 
remains unclear.  
 
Previous studies have shown that the inhibition of TLR2 has the capacity to 
reduce inflammation and attenuate fibrosis in tissues such as lung and heart (Yang, 2009; 
Wang 2014). This improvement was primarily associated with a reduction in the 
infiltration of inflammatory cells, especially macrophages, the activation of NF-κB 
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pathway, and the production of inflammatory cytokines. These data suggest that TLR2 
may be involved in mediating tissue injury and fibrosis through regulating the function 
and the production of proinflammatory molecules. While the connection between TLR2 
and fibrosis development remains poorly understood, our project seeks to investigate the 
role of TLR2 in regulating myelopoiesis and systemic inflammation under HFD 
condition and explore possible mechanisms by which TLR2 achieves its effect. 
 
Examining the Role of TLR2 by Evaluating the Expression of Several Key 
Transcription Factors in Mice with 12 weeks of HFD Feeding  
Based on previous findings indicating that the expression of key transcription 
factors may be affected by HFD feeding, several key transcription factors that are 
implicated in myeloid-lineage differentiation, including C/EBPα/ε, GFI-1, PU.1, Runx1, 
GATA2/3, were selected for this study (Huang, 2017). PU.1, complementary to Runx1, 
was found to serve as a crucial regulator in determining the fate of the myeloid lineage 
during normal stem cell development (Hu, 2011). Key transcription factors involved in 
B-lymphocyte differentiation, including Ikaros and Pax-5, were also selected to examine 
the dynamic of myelopoiesis and lymphopoiesis in BM. Possessing anti-inflammatory 
characteristics, PPARγ has shown to inhibit NF-κB-dependent transcriptional activation 
in several tissue inflammations (Remels, 2009). Its inclusion in our study would assist us 
in investigating whether the absence of TLR2 would enhance the inhibitory effect of NF-
κB-associated inflammatory signaling pathways. Additionally, there has been evidence 
that p65 (RelA) serves as an important factor in hematopoiesis by regulating 
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hematopoietic stem cell function and lineage commitment - either myeloid or lymphoid 
(Stein, 2013). Determination of its expression, based on RT-qPCR analysis, would help 
us examine its interaction with other key factors involved in hematopoietic stem cell 
homeostasis.  
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SPECIFIC AIMS 
 
Studies have linked metabolic dysfunction (e.g., insulin resistance and glucose 
intolerance) and inflammation within adipose tissue. In addition, studies have 
demonstrated that neutrophils, the most abundant leukocytes in circulation that mediate 
innate immunity and acute inflammation, play a key role in interacting with other 
proinflammatory cells and initiating tissue damage. It was widely found that obese 
animals have elevated neutrophil counts, placing their bodies in a chronic inflamed state 
(Marcelin, 2017; Huang, 2017; Hotamisligil, 1995). Our previous study generated data 
indicating short-term consumption of a HFD is sufficient to increase neutrophil 
infiltration into white adipose tissue. Additionally, mice that lack neutrophil elastase 
(NE), the active digestive enzyme of neutrophils, are resistant to HFD-induced leukocyte 
infiltration to adipose tissues and insulin resistance (Huang 2017). While the exact 
regulatory mechanisms to trigger inflammation remain unclear, neutrophils may be 
involved in the inflammatory stages of HFD-induced obesity.  
 
Given that BM HSCs can differentiate into cells of the myeloid and lymphoid 
lineages, our primary focus is to study differential expression of several key transcription 
factors that are involved in myelopoiesis and lymphopoiesis in HSPCs. By investigating 
TLRs’ role in activating pathways leading to systemic inflammation, this paper seeks to 
understand the dynamic changes of neutrophil homeostasis in the BM in order to better 
understand the underlying mechanisms that drive the HFD-induced neutrophil 
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infiltration. In this study, we used a TLR2 null mouse model to investigate the role of 
TLR2 in HFD-induced neutrophil production and adipose inflammation.  
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METHODS 
 
Experimental Animals 
Homozygous TLR2 knockout mice (Tlr2tm1Kir) and WT mice were obtained from 
The Jackson Laboratory and bred at Boston University Medical Campus. For 
experimental purposes, all mice were fed a high-fat diet (HFD; 60 kcal% fat, D12492, 
Research Diets) for 12 weeks. All mouse work was performed according to the 
Institutional Animal Care and Use Committee guidelines.  
 
PCR Genotyping 
PCR Genotyping was performed in order to determine the genetic constitution of 
a group of mice by examining their DNA sequence. DNA extraction was performed using 
Qiagen DNEasy Blood & Tissue Kit. A cocktail of ATL was made with 180 µL of buffer 
ATL (tissue lysis buffer) and 20 µL Proteinase K (protease digestion). 200 µL of the 
cocktail was added to each sample’s tube and the mouse tail was fully submerge within. 
Samples were incubated at 55°C for 6-12 hours in heat block or water bath. Tubes were 
removed from heat source and vortexed. 400 µL of AL/Ethanol lysis buffer mixture was 
added to each tube, and then vortexed. Liquid was poured into appropriately labeled 
QIAprep spin columns. Columns were centrifuged at 8,000 rpm for 1 minute, and then 
transferred to a new collection tube with 500 µL of AW1 (wash buffer). It is important to 
ensure that ethanol (200 proof) has been added to AW1 buffer. Samples were centrifuged 
at 8,000 rpm for 1 minute, and then spin columns were transferred to new collection 
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tubes. 500 µL of AW2 (with 200 proof ethanol) was added to each tube, and samples 
were centrifuged at max speed (14,000 rpm) for 3 minutes. Tubes were transferred to1.4 
mL microtubes. 200 µL of Buffer AE (elution buffer) was added to spin columns in 
tubes, and they were incubated at RT for 2 minutes. Finally, the samples were centrifuged 
at 8,000 rpm for 1 minute. Elution was performed twice (for a total of 200 µL in each 
tube) per sample.  
 
To start the PCR, master mix for the PCR (14.38 µL molecular grade H2O, 2.0 µL 
10 X PCR buffer II, 1.36 µL 25 mM MgCl, 0.4 µL dNTP (10mM each), 0.5 µL Oligo’s 
(20mM each), 0.16 µL Amplitaq® (5U/µL)) was briefly vortexed and transferred 18.8 µL 
to each 200 µL thin walled reaction tube on ice. 1.2 µL of ~100 ng DNA was added to 
each reaction tube. PCR was performed using specified thermal conditions.  
 
For data analysis, a 1.2% TBE Agarose gel (~1 min per 100 mL) was prepared 
with 10 µL SyberSafe per 100 mL agarose. Pipette tips were lined with Loading Dye and 
mix with finished PCR reaction, and 75% reaction volume was injected into each well 
(15 µL). The gel was run at 120 V for 1.5 hours in TBE Buffer (1 L of 5X stock: 54 g of 
Tris base, 27.5 g of boric acid, 20 ml of 0.5 M EDTA, pH ~ 8.3). Images were captured 
under UV and were adjusted and stored for record.  The controls included non-template 
control, isogenic WT, and 1kb plus ladder.  
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Isolation of Mouse Bone Marrow Cells and Peripheral Blood Leukocytes 
Peripheral blood was obtained by cardiopuncture and collected into 
EDTA/heparin-containing tubes. Red blood cells (RBCs) were lysed by incubation for 5 
minutes with 1X BD Pharm LyseTM (lysing buffer). Cells were centrifuged at 500 x g for 
5 minutes, washed once with PBS containing 2% FBS (PBS/2% FBS), and resuspended 
at 1 x 107 cells/ml in PBS/2% FBS. BM cells were obtained by flushing the femurs and 
tibias with PBS/2% FBS. Cell clumps were dispersed with a 23G needle, RBCs were 
lysed, and the cell suspension was washed and resuspended in PBS/2% FBS. BM HSPCs 
were enriched using a mouse hematopoietic progenitor cell enrichment kit from 
STEMCELLTM Technologies, following the manufacturer’s procedures. Isolated HSPCs 
were used for RNA isolation and real-time PCR. RBCs were lysed and the cells were 
resuspended in PBS/2% FBS. Purified cells were used for real-time qPCR and FACS 
analysis. 
 
HSPC Purification 
Mouse bone marrow (BM) was surgically extracted using PBS and mixing with 1 
mL pipette. Samples were centrifuged at 500 x g for 5 minutes. The supernatant was 
discarded and the pellet was resuspended with 1 mL ACK lysing buffer. After 45 
seconds, 15 mL PBS/2% was added to stop each reaction. Samples were centrifuged at 
500 x g for 5 minutes. The supernatant was discarded and the pellet was resuspended in 1 
mL PBS. The solution was transferred into 1.5 mL Eppendorf® microcentrifuge tubes. 
Following the protocol of EasySep™ Mouse Hematopoietic Progenitor Cell Isolation Kit, 
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samples were prepared with the concentration of 1 x 108 cells/mL. Rat Serum (50 µL/mL 
of sample) was added to each sample along with Isolation Cocktail (50 µL/mL of 
sample), and samples were incubated at 4°C for 15 minutes. D Magnetic Particles were 
vortexed for 30 seconds to ensure complete mixture, and then the appropriate amount 
(150 µL/mL of sample) was added to samples. Samples were mixed and incubated on a 
rotator at 4°C for 10 minutes. PBS/2% was added to top up the sample to 1.5 mL and the 
solution was mixed by being gently pipetted up and down 3 times. Tubes, with lids open, 
were placed onto the magnetic rack and incubated at RT for 3 minutes. After 3 minutes, 
the aqueous fraction of the tube was pipetted out and transferred to a different set of 
microcentrifuge tubes, leaving the brown magnetic residue adhered to the wall. Tubes 
with leftover magnetic particles were discarded.  
 
FACS Analysis of HSPC and Matured Immune Cells  
HSPCs and immune cells (1 × 106/sample) were washed once, resuspended in 100 
µL PBS, mixed with 0.5 µL of Zombie Aqua fixable viability kit, and incubated at room 
temperature for 15 min in the dark. Cells were washed once with 2 mL PBS/2% and then 
mixed with 0.5 µg Fc receptor blocking reagent in 100 µL PBS/2% FBS at 4 °C for 15 
min. Blocking Fc receptors is a crucial step because false-positive (non-specific) results 
could be observed after immunofluorescence staining due to Fc receptor-mediated 
immunoglobulin Fc binding. Therefore, preventing non-specific binding would reduce 
background and generate more accurate data. Also, this procedure could increase the 
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specificity of antibody labeling in rare target cells such as HSPCs and antigen-specific B 
cells.  
 
Fluorochrome-conjugated primary antibodies (0.1 µg/sample) were added and the 
cells were incubated for 40 min at 4°C in the dark. Cells were washed twice and then 
analyzed using a BD LSRII flow cytometer. The data were analyzed using FlowJo v10 
software. Cell sorting was performed using a BD FACS Aria. Cells were stained with the 
following antibodies to identify the different cell subpopulations in blood and BM: anti-
Ly-6G-APC, anti-CD11b-PE, anti-Ly-6C-BV421, anti-CD19-FITC, anti-Lineage-APC, 
anti-Sca1-PE-Cy7, anti-c-Kit-PE, anti-CD34-FITC, anti-FcγRII/III-eFluor 450, and the 
relevant isotype control antibodies. Neutrophils were identified as CD11b+Ly-6G+. 
 
By default, the flow cytometer was programmed to quantify a total of 1 million 
cells from each sample for detection of the different type of cells (i.e, neutrophils, 
monocytes, B-lymphocytes) in each of our BM and blood sample. Percentages were used 
for expressing the relative abundance of each cell type in each sample. After the total cell 
numbers from the BM and blood samples were collected, the percentage of each cell type 
in each sample could be calculated. Furthermore, for specific purposes, these numbers 
could be converted into absolute cell numbers, with detailed methods shown in our 
previous study (Huang, 2017). Nonetheless, many labs only use percentage for this 
particular type of study.   
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Real-time Quantitative PCR  
After the isolation of total RNA from BM HSPCs using TRIzol reagent, RNA was 
reverse transcribed to cDNA with specified amount of primers (transcription factors in 
this study) and Reaction Mix. RT-qPCR was performed with SYBR Green JumpStart 
Taq ReadyMix, a commonly used fluorescent dye that binds dsDNA molecules by 
intercalating between the DNA bases, using a ViiA 7 Real-Time PCR System. 36b4 was 
amplified as an internal control. Due to the fact that 36b4 nucleotide sequence has highly 
conserved regions in the 5’ end of its open reading frame that cross tissue and species 
boundaries, and that the DNA sequence homology between species is high, it has been a 
reliable standard for use in gene expression analysis for various tissues. 36b4 was thus 
chosen as our housekeeping gene of controlling the experimental outcome.  
 
All samples were analyzed in triplicate. The results were expressed as the fold 
change in mRNA levels relative to the expression of 36b4 in the same samples and were 
calculated with the following formula based on two replications of each cycle: fold 
change = [efficiency (c – t) of target gene/efficiency (c – t) of 36b4 mRNA], where c 
represents the cycle threshold (Ct) for the target gene or 36b4 in the experimental control 
samples, and t represents Ct for the target gene or 36b4 in the test samples. 
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Table 1. PCR Primers 
Gene Forward Primer Reverse Primer 
PU.1 GAACAGATGCACGTCCTCG
AT 
CAAGGTTTGATAAGGGAAGCAC
AT 
GFI-1 CAGCTTACCGAGGCTCCCGA
CAGG 
CAAGACCGCTCCATGCATAGGG
CTT 
C/EBPα GAACAGCAACGAGTACCGG
GTA 
CCATGGCCTTGACCAAGGAG 
C/EBPε GAGCCGAGATAAAGCCAAA
CA 
AGGCAGCTGGCGGAAGAT 
Pax-5 CCATCAGGACAGGACATGG
AG 
GGCAAGTTCCACTATCCTTTG 
Ikaros GACGCACTCCGTTGGTAAG GCATCGCTCTTTATGCTCCTCTA 
Runx1 GCAGGCAACGATGAAAACT
ACT 
GCAACTTGTGGCGGATTTGTA 
GATA2 AGCTCATGACTATGGCAGCA CCGGTTCTGTCCATTCATCT 
GATA3 CAGAACCGGCCTCTCATCC TAGTGCATTGGGTGCCTGC 
PPARγ1 CAGGACTGTGTGACAGACA
AGA 
TGTGTCAACCATGGTAATTTCA 
PPARγ2 ATGGGTGAAACTCTGGGAG
A 
GTGCTCATAGGCAGTGCATC 
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RELA 
(p65) 
ACTGCCGGGATGGCTACTAT TCTGGATTCGCTGGGTAATGG 
36b4 TCGGGTCCTAGACCAGTGTT
C 
AGATTCGGGATATGCTGTTGGC 
 
 
Statistical Analysis 
All quantitative results are expressed as means ± SEM. Differences between two 
groups were evaluated using the unpaired Student’s t test with two-tailed distribution. A p 
value <0.05 was considered statistically significant.  
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RESULTS 
 
PCR genotyping and expression profiling distinguished genomic variations between 
WT and TLR2 KO mice.  
In this study, we are particularly interested in evaluating the differences between 
WT and TLR2 KO mice in three areas: the percentage of neutrophils in BM, the 
percentage of neutrophils in blood, and the gene expression of purified BM HSPCs. To 
examine the differential gene expression and neutrophil phenotype in WT and TLR2 KO 
mice, both groups were fed HFD (60 kcal% fat) for 12 weeks with identical breeding 
conditions at BUMC Animal Science Center (ASC). In order to ensure that genetic 
variants exist between the WT and TLR2 KO mice (C57BL/6 background), we 
performed genotyping PCR analysis by removing the distal end of each mouse’s tail 
(approx. 0.5 cm). For comparison purposes, 1 kb DNA Ladder was used in the left-most 
column. As indicated by the electrophoresis results, PCR products with the 334-bp band 
(Figure 1, left panel) reflect the absence of TLR2 genes in the mutant TLR2 KO mice, 
whereas the presence of 499-bp band indicates the genetic composition of the WT mice. 
In the right panel, the 334-bp band is subtly present possibly due to an overexposure of 
the agarose gel under the UV light. The experiment verified the knockout genotype of 
TLR2 null mice.  
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Figure 1. PCR Analysis for TLR2-/- Mouse Tail Genotyping. Determination of the 
TLR2 genotype was based on the presence of specific bands. Mutant TLR2 KO gene is 
indicated with a band at 334 bp, and WT gene is indicated with a band at 499 bp. The 
experiment was performed with 7 TLR2 KO mice and 6 WT mice. Both groups of mice 
were fed HFD (60 kcal% fat) for 12 weeks. 
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Compared to WT mice, TLR2 KO mice demonstrated a lower percentage of BM 
neutrophils and blood B-lymphocytes, and a greater percentage of BM B-lymphocytes.  
To quantify the percentage of neutrophils in BM and blood, we performed FACS 
analysis where BM and blood cells were treated with Fc receptor blocking reagent and 
incubated with specific antibodies (Refer to “FACS Analysis of HSPC and Matured 
Immune Cells” in Methods section). Given that different immune cells express different 
surface receptors, we were able to identify and quantify each cell type using antigen-
antibody interactions. As shown in Figure 2, cells were first gated for singlet cells (FSC-
H vs. FSC-W and SSC-H vs. SSC-W) and then analyzed for their uptake of Zombie-
Aqua stain to distinguish live cells and dead cells. In live cells, neutrophils were 
identified as Ly6G+CD11b+ cells; monocytes were identified as Ly6ChighCD11b+ cells 
and B-lymphocytes were identified as CD19+ cells.  
 
We found that BM neutrophils in TLR2 KO mice comprised 40% of all cells, 
compared to BM neutrophils in WT mice that comprised 44% of all cells (Figure 3). This 
significant reduction in BM neutrophils of TLR2 KO mice may indicate a regulatory role 
TLR2 plays in neutrophil production. Additionally, we observed a rise in BM B-
lymphocyte population in TLR2 KO mice (10% of all cells) comparing to B-lymphocytes 
in WT mice BM (6% of all cells). Interestingly, the percentage of blood B-lymphocytes 
in TLR2 KO mice (7% of all cells) was decreased significantly in comparison to the 
percentage of blood B-lymphocytes in WT mice (15% of all cells). The percentage of 
blood neutrophils, BM monocytes, and blood monocytes of all cells remained relatively 
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consistent without significant differences across two groups of mice (WT vs. TLR2 KO; 
Figure 3).   
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Figure 2. Flow cytometry gating strategies for identification of leukocytes and BM 
hematopoietic stem cells and progenitor cells (HSPCs). Cells were first gated for 
singlet cells (FSC-H vs. FSC-W and SSC-H vs. SSC-W) and then analyzed for their 
uptake of Zombie-Aqua stain to determine live versus dead cells. In live cells, neutrophils 
were identified as Ly6G+CD11b+ cells; monocytes were identified as Ly6ChighCD11b+ 
cells and B-lymphocytes were identified as CD19+ cells. For HSPC analyses, BM cells 
were first gated for singlet cells (FSC-H vs. FSC-W and SSC-H vs. SSC-W) and then 
analyzed for their uptake of the Zombie-Aqua stain to determine live versus dead cells.  
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Figure 3. FACS comparative analysis of percentage of neutrophils, monocytes, and 
B-lymphocytes in WT vs. TLR2 KO mice. WT and TLR2 KO mice were fed HFD (60 
kcal% fat) for 12 weeks. BM and blood samples were analyzed by FACS. The graph 
shows the percentage of cells, not the absolute number of cells, that were neutrophils, 
monocytes, and B-lymphocytes. (BM samples: WT n = 6; TLR2 KO n = 6. Blood 
samples: WT n = 5; TLR2 KO n = 6. *p < 0.05, WT vs. TLR2 KO).  
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TLR2 KO mice demonstrated decreased expression in key transcription factors 
involved in myelopoiesis.  
The expression of 4 key transcription factors associated with the differentiation of 
myeloid lineage (i.e., C/EBPα/ε, GFI-1, PU.1, and Runx1) was shown to be significantly 
decreased in TLR2 KO mice, compared to WT mice (Figure 4). Between the two groups, 
no significant differences were observed in expression of Pax-5, GATA2/3, PPARγ1/2, 
p65, and Ikaros.  
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Figure 4. RT-qPCR analysis of hematopoietic factors in BM HSPCs of WT vs. 
TLR2 KO mice on 12-week HFD. The figure presents the RT-qPCR analysis of 
hematopoietic transcription factors in purified BM HSPCs. (WT n = 4; TLR2 KO n = 4. 
*p < 0.05, WT vs. TLR2 KO).  
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DISCUSSION 
 
TLR2 activation may be responsible for enhanced myelopoiesis and neutrophil 
production in BM under HFD condition.  
The data collected from flow cytometry would confirm our theory that TLR2 
plays an important role in triggering a cascade of intracellular signaling pathways that 
ultimately leads to BM myelopoiesis. It is known that neutrophils are developed from 
HSCs through a series of selective differentiation that can be induced by key transcription 
factors. When this process becomes upregulated, overstimulation of neutrophil synthesis 
can lead to vascular damage and systemic inflammation (Huang, 2017). As shown in 
Figure 3, the percentage of BM neutrophil in TLR2 KO mice was significantly reduced, 
consistent with our RT-qPCR data where the mRNA expression of myelopoietic 
transcription factors was decreased. Consistent with our hypothesis, BM B-lymphocyte 
percentage in TLR2 KO mice showed a significant increase in comparison to WT mice. 
Similar to the results from our previous study on HFD-induced changes in myelopoiesis 
and lymphopoiesis, TLR2 KO mice demonstrated a reduced percentage of neutrophils 
and an increased percentage of B-lymphocytes in mouse BM, compared to WT mice 
(Huang, 2017).  
 
Findings from this study were consistent with a previous study where we 
investigated neutrophil function and production under a 3-day HFD condition (Huang, 
2017). We found that this short-term HFD was associated with an increase in the number 
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of BM neutrophils, a hematopoietic response that occurs with severe bacterial infection. 
Additionally, we found that this short-term HFD feeding selectively activates 
transcription factors that favor myelopoiesis at the expense of lymphopoiesis in BM 
(Huang, 2017). According to the current data, we believe that TLR2 is also involved in 
this process, although the specific mechanism remains unclear. 
 
Interestingly, our FACS analysis data also showed that the percentage of blood B-
lymphocyte, along with BM neutrophils, was significantly decreased in TLR2 KO mice 
in comparison to WT mice (Figure 3). Given our knowledge with the myeloid and 
lymphoid lineage (Huang, 2017), it was an unexpected finding since we hypothesized 
both blood and BM lymphocyte populations would increase in mice lacking TLR2. This 
indicates a possibility that the release of B-lymphocytes from BM into circulation is 
tightly regulated through a mechanism that may or may not be related to TLR2.  
Additional experiments are required to confirm the accuracy of the findings, and 
hypotheses shall be adjusted accordingly. 
 
TLR2 KO mice can be protected from HFD-induced gene expression changes of key 
transcription factors.  
Based on our RT-qPCR data, WT mice demonstrated greater levels of expression 
of transcription factors in HSPCs that are involved in myeloid differentiation, including 
C/EBPα/ε, GFI-1, PU.1, and Runx1 (Figure 4). These factors are all related to the 
development and maturation of neutrophils. Under the condition of HFD feeding, TLR2 
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KO mice demonstrated reduced myelopoiesis in association with reduced expression of 
these activators. In other words, TLR2 KO mice, in comparison to WT mice, appeared to 
be protected from HFD-induced gene expression changes that are observed in diet-
induced chronic myelopoiesis.  
 
In our previous study that compared mice on NCD vs. HFD for 3 days, RT-qPCR 
data showed that HFD feeding profoundly increased the mRNA expression of PU.1, 
C/EBPα, C/EBPε, and GFI-1 in HSPCs. However, levels of Pax-5 mRNA, necessary for 
encoding the B-cell lineage specific activator protein, decreased significantly in HSPCs 
after HFD feeding (Huang, 2017). As a result, HFD feeding was found to have an effect 
of increasing myeloid cell differentiation and neutrophil production but reducing B-
lymphocyte production in BM. Additionally, further analysis demonstrated that the 
expression of the active p42 C/EBPα protein was elevated in BM cells from HFD-fed 
mice, and conversely, the expression of its p30 isoform, which in this case acts as a 
dominant-negative inhibitor, was reduced. Mice fed with NCD demonstrated lower p42 
to p30 C/EBPα ratio, consistent with less myelopoiesis (Huang, 2017).  
 
Since the absence of TLR2 was shown to be associated with reduced percentage 
of neutrophils in BM, it is likely that the TLR2 possesses critical regulatory effects on 
hematopoiesis during HFD feeding. With the understanding that TLR2 KO mice seemed 
to be protected from HFD-induced gene expression changes of key transcription factors 
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in myelopoiesis, TLR2 may become an effective therapeutic target for treating obesity-
related systemic inflammation in a wide array of metabolic syndromes.   
 
Considering previous results, TLR2-mediated changes in gene expression and 
transcriptional activity may be reversed by NE deletion. 
From a previous study, we observed that BM cells from NE KO mice expressed 
significantly more of the dominant-negative p30 C/EBPα isoform than WT mice (Huang, 
2017). Additionally, WT mice fed with HFD demonstrated greater NE protein levels in 
BM and NE mRNA levels in BM neutrophils and HSPCs. NE KO mice on HFD showed 
significantly lower number of neutrophils and monocytes, but greater number of B-
lymphocytes, in the BM and blood, compared with HFD-fed WT mice (Huang, 2017). It 
is shown that NE deletion was able to prevent the HFD-induced gene expression changes 
in WT mice. Furthermore, there was a significant loss of neutrophils and monocytes from 
the BM and blood of mice lacking C/EBPα, a transcriptional activator that was earlier 
found to be involved in the HFD-induced myeloid cell differentiation. Interestingly, mice 
with either NE or C/EBPα knocked out are resistant to HFD-induced myelopoiesis 
(Huang, 2017). 
 
Comparing findings from the current study and the previous one, it is suggested 
that a connection between TLR2 and NE exists due to the fact that deletion of either gene 
produced similar results. While TLR2-mediated pathways can induce a systemic 
elevation of proinflammatory cytokine expression, a selective KO on NE gene may 
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possibly grant HSPCs protections from the negative consequences of diet-induced 
inflammation. Our collective data indicated that TLR2 may play a role in mediating 
HFD-induced myelopoietic pathway; however, the exact molecular mechanisms by 
which TLR2 affects neutrophil half-life and phenotype remain unclear. Gaining more 
understanding in the BM molecular events of obesity-related complications may greatly 
contribute to the developing of therapeutic interventions, such as small TLR2 molecular 
antagonists or anti-inflammatory drugs. It would be an interesting topic for future 
discussions and studies. 
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